New bone formation in nude mouse calvaria induced by canine prostate tissue

Molecular and Cellular Endocrinology

Volumn 197, Issue 1-2, 2002, Pages 257-263

  LeRoy, Bruce E ^a   Bahnson, Robert R ^a   Rosol, Thomas J ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Bone formation; Dog; Osteoblastic metastases; Prostate cancer; Prostate gland

Indexed keywords

ACID PHOSPHATASE; CALCEIN; COLLAGENASE; TARTARIC ACID; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; FLUORESCEIN DERIVATIVE; ISOENZYME; TARTRATE-RESISTANT ACID PHOSPHATASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOLOGICAL MODEL; BLADDER; BONE MINERALIZATION; CALVARIA; CELL COUNT; CONTROLLED STUDY; DOG; IMPLANT; KIDNEY PARENCHYMA; MALE; MICROENVIRONMENT; MOUSE; NONHUMAN; NUDE MOUSE; OSSIFICATION; OSTEOCLAST; PERIOSTEUM; PRIORITY JOURNAL; PROSTATE; SKELETAL MUSCLE; SPLEEN; STAINING; TISSUE SLICE; ANIMAL; BONE DEVELOPMENT; CYTOLOGY; HUMAN; METABOLISM; PHYSIOLOGY; SKULL; TISSUE TRANSPLANTATION; TRANSPLANTATION; XENOGRAFT;

ACID PHOSPHATASE; ANIMALS; CALCIFICATION, PHYSIOLOGIC; DOGS; FLUORESCEINS; HUMANS; ISOENZYMES; MALE; MICE; MICE, NUDE; OSTEOCLASTS; OSTEOGENESIS; PROSTATE; SKULL; TISSUE TRANSPLANTATION; TRANSPLANTATION, HETEROLOGOUS;

EID: 0037195508     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(02)00260-5     Document Type: Article

References (32)

1. Barengolts, E.I., Lathon, P.V., Kukreja, S.C. 1997. Effect of various parathyroid hormone-related proteins (PTHrP) fragments on bone resorption and formation in vivo [abstract]. American Society for Bone and Mineral Research 18th Annual Meeting, S449.
2. Barrack E.R. TGFβ in prostate cancer: a growth inhibitor that can enhance tumorigenicity. Prostate. 31:(1):1997;61-70.
3. Bentley H., Hamdy F.C., Hart K.A., Seid J.M., Williams J.L., Johnstone D., Russell R.G. Expression of bone morphogenetic proteins in human prostatic adenocarcinoma and benign prostatic hyperplasia. Br. J. Cancer. 66:1992;1159-1163.
4. Blomme E.A., Dougherty K.M., Pienta K.J., Capen C.C., Rosol T.J., McCauley L.K. Skeletal metastasis of prostate adenocarcinoma in rats: morphometric analysis and role of parathyroid hormone-related protein. Prostate. 39:1999;187-197.
5. Blomme E.A., Sugimoto Y., McCauley L.K., Lin Y.C., Capen C.C., Rosol T.J. Stromal and epithelial cells of the canine prostate express parathyroid hormone-related protein, but not the PTH/PTHrP receptor. Prostate. 36:1998;110-120.
6. Castro J.E. A method of in vivo maintenance of human prostatic tissue in immunosuppressed mice. Br. J. Urol. 45:1973;163-168.
7. Deftos L.J. Prostate carcinoma: production of bioactive factors. Cancer. 88:2000;3002-3008.
8. Fenton A.J., Kemp B.E., Kent G.N., Moseley J.M., Zheng M.H., Rowe D.J., Britto J.M., Martin T.J., Nicholson G.C. A carboxyl-terminal peptide from the parathyroid hormone-related protein inhibits bone resorption by osteoclasts. Endocrinology. 129:1991;1762-1768.
9. Guise T.A. Parathyroid hormone-related protein and bone metastases. Cancer. 80:1997;1572-1580.
10. Guise T.A. Molecular mechanisms of osteolytic bone metastases. Cancer. 88:2000;2892-2898.
11. Guise T.A., Mundy G.R. Cancer and bone. Endocr. Rev. 19:1998;18-54.
12. Harris S.E., Harris M.A., Mahy P., Wozney J., Feng J.Q., Mundy G.R. Expression of bone morphogenetic protein messenger RNAs by normal rat and human prostate and prostate cancer cells. Prostate. 24:1994;204-211.
13. Iddon J., Bundred N.J., Hoyland J., Downey S.E., Baird P., Salter D., McMahon R., Freemont A.J. Expression of parathyroid hormone-related protein and its receptor in bone metastases from prostate cancer. J. Pathol. 191:2000;170-174.
14. Ishizaka K., Azuma H., Matsubara O., Kitahara S., Oshima H. Production of endothelin by canine prostatic epithelial cells and its stimulatory effects on their growth. J. Androl. 20:1999;529-536.
15. Iwamura M., di Sant'Agnese P.A., Wu G., Benning C.M., Cockett A.T., Deftos L.J., Abrahamsson P.A. Immunohistochemical localization of parathyroid hormone-related protein in human prostate cancer. Cancer Res. 53:(8):1993;1724-1726.
16. Iwamura M., Hellman J., Cockett A.T., Lilja H., Gershagen S. Alteration of the hormonal bioactivity of parathyroid hormone-related protein (PTHrP) as a result of limited proteolysis by prostate-specific antigen. Urology. 48:1996;317-325.
17. Koutsilieris M. Osteoblastic metastasis in advanced prostate cancer. Anticancer Res. 13:1993;443-449.
18. Leav I., Schelling S.H., Merk F.B. Age-related and sex hormone-induced changes in the canine prostate. Mohr U., et al. Pathobiology of the Aging Dog. first ed. 2001;310-329 Iowa State University Press, Ames.
19. McCormack R.T., Rittenhouse H.G., Finlay J.A., Sokoloff R.L., Wang T.J., Wolfert R.L., Lilja H., Oesterling J.E. Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era. Urology. 45:(5):1995;729-744.
20. Mundy G., Garrett R., Harris S., Chan J., Chen D., Rossini G., Boyce B., Zhao M., Gutierrez G. Stimulation of bone formation in vitro and in rodents by statins. Science. 286:1999;1946-1949.
21. Mundy G., Yoneda T. Mechanisms of bone metastasis. Orr F.W., Singh G., Bone Metastasis - Mechanisms and Pathophysiology. 1996;1-16 RG Landes Company, Austin.
22. Nelson J.B., Carducci M.A. The role of endothelin-1 and endothelin receptor antagonists in prostate cancer. Br. J. Urol. Int. 85:(Suppl. 2):2000;45-48.
23. Nelson J.B., Nguyen S.H., Wu-Wong J.R., Opgenorth T.J., Dixon D.B., Chung L.W., Inoue N. New bone formation in an osteoblastic tumor model is increased by endothelin-1 overexpression and decreased by endothelin A receptor blockade. Urology. 53:1999;1063-1069.
24. Peehl D.M., Edgar M.G., Cramer S.D., Deftos L.J. Parathyroid hormone-related protein is not an autocrine growth factor for normal prostatic epithelial cells. Prostate. 31:(1):1997;47-52.
25. Quinn J.E., Buhler K.R., Brown J.M., Brown L., Vessella R.L. A model for prostate cancer bone metastasis: direct intra-bone injection of prostate cancer xenografts. Cancer. 88:2000;3100. Abstract.
26. Rabbani S.A., Xing R.H. Role of urokinase (uPA) and its receptor (uPAR) in invasion and metastasis of hormone-dependent malignancies. Int. J. Oncol. 12:1998;911-920.
27. Roodman G.D. Cell biology of the osteoclast. Exp. Hematol. 27:(8):1999;1229-1241.
28. Rosol T.J., Capen C.C., Horst R.L. Effects of infusion of human parathyroid hormone-related protein-(1-40) in nude mice: histomorphometric and biochemical investigations. J. Bone Miner. Res. 3:1988;699-706.
29. Russell P.J., Bennett S., Joshua A., Yu Y., Downing S.R., Hill M.A., Kingsley E.A., Mason R.S., Berry J. Elevated expression of FGF-2 does not cause prostate cancer progression in LNCaP cells. Prostate. 40:1999;1-13.
30. Waters D.J., Hayden D.W., Bell F.W., Klausner J.S., Qian J., Bostwick D.G. Prostatic intraepithelial neoplasia in dogs with spontaneous prostate cancer. Prostate. 30:1997;92-97.
31. Yamada Y., Tozawa K., Cui L., Takahashi S., Shirai T., Kohri K. Characteristics of nonneoplastic human prostate tissue transplanted into nude mice. Prostate. 37:1998;109-115.
32. Zhau H.E., Li C.L., Chung L.W. Establishment of human prostate carcinoma skeletal metastasis models. Cancer. 88:2000;2995-3001.